Peripheral venous

blood was obtained from https://www.selleckchem.com/Wnt.html healthy donors and patients with cholestatic disorders, uremia, Hodgkin’s disease, and atopic dermatitis after informed consent, according to the Declaration of Helsinki. The study was approved by the local medical ethical committees. Treatment interventions, such as colesevelam,12 RMP, MARS therapy, and nasobiliary drainage,7 were conducted, recorded, and reported on in compliance with the International Conference on Harmonization Good Clinical Practice and national regulations. Blood samples were allowed to clot for 1 hour before they were centrifuged at 4°C, and serum was cryopreserved in aliquots at −80°C. Itch intensity was quantified in all patients at the time point of blood drawing using a visual analog scale (VAS) ranging from 0 (no pruritus) to 100 (unbearable pruritus). In the colesevelam study,12 35 patients were evaluable, of whom 17 patients received colesevelam (1,875 mg twice-daily) and 18 patients were treated with an identical placebo selleck products for 3 weeks. The study population

consisted of 22 female and 13 male patients being mainly diagnosed for PBC (N = 14) or PSC (N = 14). MARS treatment was performed in 10 patients (8 female and 2 male) with intractable pruritus resulting from PBC (n = 6), PSC (n = 2), or other liver disorders (n = 2; Supporting Table 4). Choline oxidase (ChO), horseradish peroxidase (HRP), homovanillinic acid (HVA), dimethyl sulfoxide (DMSO), bovine serum albumine

(BSA), and RMP were purchased from Sigma-Aldrich (Steinheim, Germany); stearoyl LPA (18:1) and myristoyl LPC (14:0) were from Avanti Lipids (Alabaster, AL). Human HepG2 hepatoma cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; Lonza BioWhittaker, Cologne, Germany) supplemented with 10% fetal Branched chain aminotransferase calf serum, 4 mM of L-glutamine, and a mixture of antibiotics (5 mg/mL of penicillin and 5 mg/mL of streptomycin). Cells were incubated at 37°C in a humidified atmosphere containing 5% CO2. For studying the effect of RMP, cells were seeded in six-well plates at a density of 8 × 105 cells/well until reaching 80% confluence. Subconfluent cells were cultured overnight in serum-free medium containing 0.2% BSA. After brief washing, cells were incubated for 24 hours in DMEM/0.2% BSA containing 10 μM of RMP. As a solvent control, 0.1% DMSO was added to control cells. HepG2 cells overexpressing PXR and PXR knock-down HepG2 cells (see below) were identically analyzed.